Jay Y. Spiegel, Matthew C. Cheung, Hany R. Guirguis, Rena J. Buckstein
Abstract
The International Prognostic Index (IPI) is a clinical prognostic tool used for more than 20 years in the risk stratification of patients with de novo diffuse large B cell lymphoma (DLBCL) who rece...
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The International Prognostic Index (IPI) is a clinical prognostic tool used for more than 20 years in the risk stratification of patients with de novo diffuse large B cell lymphoma (DLBCL) who rece...
Key concepts: Diffuse large B-cell lymphoma, International Prognostic Index, Medicine, Lymphoma, Risk stratification, Internal medicine, Oncology